Cisplatin+Pembrolizumab+RT in Vulvar Cancer

NCT04430699 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Vulvar Cancer
Vulvar Squamous Cell Carcinoma

Interventions

DRUG: Cisplatin
DRUG: Pembrolizumab
RADIATION: Radiation Therapy

Sponsor

Massachusetts General Hospital

Collaborators

[object Object]